Lakeland Industries, Inc. (NASDAQ:LAKE – Get Free Report) CRO Barry Phillips acquired 1,250 shares of the stock in a transaction dated Tuesday, December 23rd. The shares were purchased at an average price of $8.71 per share, for a total transaction of $10,887.50. Following the completion of the transaction, the executive owned 18,802 shares of the company’s stock, valued at $163,765.42. This trade represents a 7.12% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Lakeland Industries Stock Performance
Shares of NASDAQ LAKE traded up $0.10 during trading hours on Monday, reaching $8.74. The stock had a trading volume of 161,396 shares, compared to its average volume of 153,455. The company has a market cap of $85.70 million, a price-to-earnings ratio of -1.99 and a beta of 1.33. Lakeland Industries, Inc. has a twelve month low of $7.77 and a twelve month high of $27.28. The business’s fifty day moving average is $13.79 and its two-hundred day moving average is $14.31. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.83 and a quick ratio of 1.48.
Lakeland Industries (NASDAQ:LAKE – Get Free Report) last announced its quarterly earnings results on Wednesday, September 21st. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter. Lakeland Industries had a negative net margin of 19.41% and a negative return on equity of 7.80%. The firm had revenue of $27.47 million for the quarter. As a group, research analysts expect that Lakeland Industries, Inc. will post 0.48 EPS for the current year.
Lakeland Industries Announces Dividend
Hedge Funds Weigh In On Lakeland Industries
Several institutional investors have recently bought and sold shares of the business. Royce & Associates LP grew its holdings in shares of Lakeland Industries by 10.0% during the third quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock worth $17,444,000 after purchasing an additional 107,100 shares during the last quarter. Private Capital Management LLC lifted its position in Lakeland Industries by 1.2% during the 3rd quarter. Private Capital Management LLC now owns 1,169,488 shares of the medical instruments supplier’s stock worth $17,308,000 after buying an additional 14,415 shares in the last quarter. Vanguard Group Inc. grew its holdings in Lakeland Industries by 2.3% during the 3rd quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier’s stock worth $7,201,000 after acquiring an additional 10,764 shares during the last quarter. First Eagle Investment Management LLC increased its position in Lakeland Industries by 27.3% in the 2nd quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier’s stock valued at $3,794,000 after acquiring an additional 59,803 shares in the last quarter. Finally, Ancora Advisors LLC increased its position in Lakeland Industries by 85.1% in the 1st quarter. Ancora Advisors LLC now owns 276,688 shares of the medical instruments supplier’s stock valued at $5,620,000 after acquiring an additional 127,195 shares in the last quarter. Institutional investors own 71.69% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. Lake Street Capital decreased their price objective on Lakeland Industries from $26.00 to $19.00 and set a “buy” rating on the stock in a report on Wednesday, December 10th. UBS Group set a $14.00 target price on Lakeland Industries in a research report on Wednesday, December 10th. Wall Street Zen cut Lakeland Industries from a “hold” rating to a “strong sell” rating in a research report on Saturday, December 13th. Roth Capital dropped their price objective on Lakeland Industries from $27.00 to $19.00 and set a “buy” rating for the company in a research note on Wednesday, December 10th. Finally, DA Davidson restated a “neutral” rating and issued a $14.00 target price (down previously from $20.00) on shares of Lakeland Industries in a research note on Wednesday, December 10th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $16.50.
View Our Latest Research Report on Lakeland Industries
Lakeland Industries Company Profile
Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.
The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.
Further Reading
- Five stocks we like better than Lakeland Industries
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.
